KEYTRUDA plus Padcev improves survival for bladder cancer patients
Investing.com - Schneider National (NYSE: SNDR) reported second quarter EPS of $0.45, $0.01 better than the analyst estimate of $0.44. Revenue for the quarter came in at $1.3B versus the consensus estimate of $1.43B.
Guidance
Schneider National sees FY 2023 EPS of $1.75-$1.90 versus the analyst consensus of $1.98.
Schneider National's stock price closed at $30.82. It is up 15.52% in the last 3 months and up 26.78% in the last 12 months.
Schneider National saw 0 positive EPS revisions and 15 negative EPS revisions in the last 90 days. See Schneider National's stock price’s past reactions to earnings here.
According to InvestingPro, Schneider National's Financial Health score is "great performance".
Check out Schneider National's recent earnings performance, and Schneider National's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar